Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santiago Avila-Rios

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|September 15, 2025
Mapping early PRC2 nucleation sites upon Suz12 reintroduction reveals features of <i>de novo</i> Polycomb recruitmentItzel Alejandra Hernández-Romero, Carlos Alberto Peralta-Alvarez, Abraham Román-Figueroa, et al.
Scientific Reports|February 2, 2020
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testingEmma R Lee, Neil Parkin, Cheryl Jennings, et al.
Iscience|April 24, 2023
SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patientsBenjamin Charvet, Joanna Brunel, Justine Pierquin, et al.
Scientific Reports|October 30, 2021
Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomesAlejandra Hernández-Terán, Fidencio Mejía-Nepomuceno, María Teresa Herrera, et al.
Viruses|July 2, 2020
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance GenotypingNeil T Parkin, Santiago Avila-Rios, David F Bibby, et al.
AIDS (London, England)|June 27, 2017
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infectionHiroyuki Gatanaga, Zabrina L Brumme, Emily Adland, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Neutralization activity in chronic HIV infection is characterized by a distinct programming of follicular helper CD4 T cellsEirini Moysi, Ashish A Sharma, Sijy O'Dell, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Cell Reports|May 31, 2024
Human antibodies in Mexico and Brazil neutralizing tick-borne flavivirusesTomás Cervantes Rincón, Tania Kapoor, Jennifer R Keeffe, et al.
Journal of Virology|September 14, 2012
Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitopePhilippa C Matthews, Madoka Koyanagi, Henrik N Kløverpris, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|September 15, 2025
Mapping early PRC2 nucleation sites upon Suz12 reintroduction reveals features of <i>de novo</i> Polycomb recruitmentItzel Alejandra Hernández-Romero, Carlos Alberto Peralta-Alvarez, Abraham Román-Figueroa, et al.
Scientific Reports|February 2, 2020
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testingEmma R Lee, Neil Parkin, Cheryl Jennings, et al.
Iscience|April 24, 2023
SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patientsBenjamin Charvet, Joanna Brunel, Justine Pierquin, et al.
Scientific Reports|October 30, 2021
Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomesAlejandra Hernández-Terán, Fidencio Mejía-Nepomuceno, María Teresa Herrera, et al.
Viruses|July 2, 2020
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance GenotypingNeil T Parkin, Santiago Avila-Rios, David F Bibby, et al.
AIDS (London, England)|June 27, 2017
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infectionHiroyuki Gatanaga, Zabrina L Brumme, Emily Adland, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Neutralization activity in chronic HIV infection is characterized by a distinct programming of follicular helper CD4 T cellsEirini Moysi, Ashish A Sharma, Sijy O'Dell, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Cell Reports|May 31, 2024
Human antibodies in Mexico and Brazil neutralizing tick-borne flavivirusesTomás Cervantes Rincón, Tania Kapoor, Jennifer R Keeffe, et al.
Journal of Virology|September 14, 2012
Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitopePhilippa C Matthews, Madoka Koyanagi, Henrik N Kløverpris, et al.
Pageof 5